Zolmitriptan

규격

139264-17-8CAS 번호

629-919-0EC 번호

(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-oneIUPAC 명칭

C16H21N3O2화학식

287.36 g/mol분자량

zolmitriptan; 139264-17-8; Zomig; Zomigoro; Zomig-ZMT; 311C90; AscoTop; zolmitriptanum; DTXSID8045933; Cvt-427; 2FS66TH3YW; NSC-760383; (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; DTXCID6025933; CHEBI:10124; 311-C-90; 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (S)-; 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one; (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one; Zolmiptriptan; Zolmitriptan OD; 4-((3-(2-dimethylaminoethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one; (4S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-1,3-oxazolidin-2-one; (4S)-4-((3-(2-dimethylaminoethyl)-1H-indol-5-yl)methyl)-1,3-oxazolidin-2-one; (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-1,3-oxazolidin-2-one; (S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; RefChem:57200; N02CC03; 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-,(S)-; 629-919-0; Flezol; Zomigon; (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one; AscoTopand; BW-311C90; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-; MFCD00871503; CHEMBL1185; Zomig Nasal Spray; Zomig ZMT; Zolmitriptan [USAN]; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; zipton; zolmitriptane; zominat; Rapimelt; (4S)-4-((3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)METHYL)-2-OXAZOLIDINONE; SMR000449310; CAS-139264-17-8; Zomig (TN); Zolmitriptan RapidFilm; UNII-2FS66TH3YW; Zolmitriptan [USAN:INN:BAN]; (S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one; (S)-4-[[3-[2-(Dimethylamino)ethyl]indol-5-yl]methyl]-2-oxazolidinone; Zolmitriptan CRS; NCGC00095155-01; KS-5072; Spectrum2_000728; ZOLMITRIPTAN [MI]; ZOLMITRIPTAN [INN]; ZOLMITRIPTAN [JAN]; GTPL60; (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone; ZOLMITRIPTAN [VANDF]; SCHEMBL33336; ZOLMITRIPTAN [MART.]; MLS000758208; MLS001424172; BIDD:GT0040; SPECTRUM1505281; ZOLMITRIPTAN [USP-RS]; ZOLMITRIPTAN [WHO-DD]; SPBio_000656; Zolmitriptan (JAN/USP/INN); orb1226378; orb1309803; SCHEMBL29356689; Zolmitriptan - Bio-X trade mark; Zolmitriptan, >=98% (HPLC); GLXC-05182; HMS1922B04; HMS2052K17; HMS2093O14; HMS2235I22; HMS3714H11; HMS3884A06; Pharmakon1600-01505281; ZOLMITRIPTAN [ORANGE BOOK]; ZOLMITRIPTAN [EP MONOGRAPH]; HY-B0229; Tox21_111455; ZOLMITRIPTAN [USP MONOGRAPH]; BDBM50033383; CCG-38993; EBC-26462; HB1801; MSK168257; NSC760383; (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one; (S)-4-[[3-[2-(Dimethylamino)ethyl]-5-indolyl]methyl]oxazolidin-2-one; AKOS015850706; Tox21_111455_1; DB00315; FZ28774; NC00382; NSC 760383; (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine; NCGC00263884-02; NCGC00263884-03; NCGC00263884-06; NCGC00263884-08; BZ164590; SY057937; BW-311C90;311C90; SBI-0206762.P001; SW197762-2; Z0024; Z5745; C07218; D00415; AB00698244-05; AB00698244_06; EN300-18567396; F036593; Q218820; SR-05000001693; SR-05000001693-1; BRD-K54314721-001-09-4; BRD-K54314721-001-10-2; Zolmitriptan, United States Pharmacopeia (USP) Reference Standard; (s)-4-{3-[2-(dimethylamino)ethyl]-1h-indol-5-ylmethyl}oxazolidin-2-one; (4S)-4-((3-(2-(Dimethylamino)ethyl) -1H-indol-5-yl)methyl)-2-oxazolidinone; (S) -N,N-Dimethyl-2- [5- (2-oxo-1,3-oxazolidin-4-ylmethyl) -1H -indol-3-yl]ethylamine; (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H -indol-3-yl]ethylamine; 139264-25-8동의어